Skip to content
★ Sign in to follow
AC

Ambra Constance M. D

Albany Molecular Research Inc
Total declarations
30
Company
1
▲ Purchases (1 ops.)
€30k
▼ Sales (17 ops.)
€4.7M

Latest filing published 10 Nov 2015 for ALBANY MOLECULAR RESEARCH INC, €913k.

Insider track record

Disclosed buys
1
Disclosed sells
17
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ambra Constance M. D: trading record in brief

Ambra Constance M. D discloses dealings in Albany Molecular Research Inc to SEC (Form 4). We count 30 filings; the first trade dates from 25 May 2006 and the latest from 9 November 2015.

Both buying and selling appear: 1 purchase worth €30k, against 17 sales worth €4.7M. Sales outweigh purchases by €4.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2015 alone, the filings show no purchases and 7 sales.

The record was last updated on 10 November 2015 with an open-market sale (€913k) in Albany Molecular Research Inc. The most recent open-market purchase was published on 19 November 2012, 5,103 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ambra Constance M. D

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations